Universal Biosensors Inc 's ability to collect accounts receivable sequentially worsen to 3.03, indicating more challenging environment then in the first quarter 2025, but still, it is a far cry from any concerns. Universal Biosensors Inc 's Accounts Receivable average collection period in the Jun 30 2025 quarter, has increased to 120 days, from 102 days, in the Mar 31 2025 quarter.

If we take a look into Healthcare sector 428 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2025 from 2812 to 2825.

What is Receivable Turnover Ratio?
What is Universal Biosensors Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

UBI Receivables Turnover Ratio	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Receivable Change	73.66 %	74.95 %	20.28 %	13.77 %	91.8 %
Y / Y Revenue Change	-27.72 %	0.99 %	-	-0.29 %	22.97 %
Receivable Turnover Ratio (TTM)	3.03	3.57	4.05	3.2	3.34
UBI's Total Ranking	# 2825	# 2812	# 3011	# 0	# 0
Accounts Receivable average collection period days	120	102	90	114	109
Seq. Receivable Change	-17.44 %	-4.75 %	2.15 %	116.2 %	-16.83 %
Seq. Revenue Change	-20.63 %	-13.55 %	-9.76 %	16.74 %	10.89 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 155
Healthcare Sector	# 429
Overall Market	# 2825

Receivable Turnover Ratio Statistics
High	Average	Low
0.17	0.1	-0.05
(Mar 31 2025)

UBI Company Profile • Back to UBI Efficiency Comparisons • Compare UBI Receivables Turnover Ratio to its Competitors

Financial Statements
Universal Biosensors Inc 's Accounts Receivable	$ 1 Millions	Visit UBI's Balance sheet
Universal Biosensors Inc 's Sales TTM	$ 4 Millions	Visit UBI's Income Statement
Sources of UBI's Revenues		Visit UBI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
UBI's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
UBI's Growth Rates	UBI's Roa	UBI's Inventory Turnover Ratio	UBI's Dividend Comparisons
UBI's Profitability Ratios	UBI's Roi	UBI's Asset Turnover Ratio	UBI's Dividend Growth
UBI's Valuation Ratios	UBI's Roe	UBI's Financial Strength Ratios	UBI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2025	Receivable at quarter ending Jun 30 2025
Radnet Inc	9.72	$ 1,907.872 Millions	$ 196.254 Millions
Cannapharmarx Inc	9.69	$ 1.361 Millions	$ 0.141 Millions
Biodesix Inc	9.65	$ 76.556 Millions	$ 7.932 Millions
Quidelortho Corp	9.63	$ 2,741.600 Millions	$ 284.575 Millions
Grail Inc	9.59	$ 134.285 Millions	$ 13.996 Millions
Surmodics Inc	9.55	$ 120.801 Millions	$ 12.652 Millions
Dynatronics Corporation	9.51	$ 27.393 Millions	$ 2.879 Millions
Adaptimmune Therapeutics Plc	9.42	$ 65.085 Millions	$ 6.912 Millions
Lifestance Health Group Inc	9.41	$ 1,316.483 Millions	$ 139.954 Millions
Encompass Health Corporation	9.41	$ 5,669.100 Millions	$ 602.775 Millions
Alpha Pro Tech Ltd	9.40	$ 57.198 Millions	$ 6.088 Millions
10x Genomics Inc	9.38	$ 642.568 Millions	$ 68.478 Millions
United Therapeutics Corporation	9.31	$ 3,077.800 Millions	$ 330.600 Millions
Madrigal Pharmaceuticals Inc	9.17	$ 515.547 Millions	$ 56.236 Millions
Viemed Healthcare Inc	9.15	$ 240.884 Millions	$ 26.325 Millions
Jaguar Health Inc	9.13	$ 11.810 Millions	$ 1.293 Millions
Ss Innovations International Inc	9.13	$ 32.503 Millions	$ 3.560 Millions
Enanta Pharmaceuticals Inc	9.12	$ 64.806 Millions	$ 7.104 Millions
Bellevue Life Sciences Acquisition Corp	9.11	$ 3.532 Millions	$ 0.388 Millions
Zynex inc	9.05	$ 144.859 Millions	$ 16.011 Millions
The Pennant Group Inc	8.98	$ 798.923 Millions	$ 89.010 Millions
Novavax inc	8.96	$ 1,078.718 Millions	$ 120.457 Millions
Editas Medicine Inc	8.90	$ 38.902 Millions	$ 4.373 Millions
Vystar Corporation	8.89	$ 0.085 Millions	$ 0.010 Millions
Veracyte Inc	8.80	$ 439.665 Millions	$ 49.982 Millions
Biotricity Inc	8.78	$ 14.237 Millions	$ 1.622 Millions
Catalyst Pharmaceuticals Inc	8.56	$ 558.499 Millions	$ 65.218 Millions
Celldex Therapeutics inc	8.56	$ 5.791 Millions	$ 0.677 Millions
Insulet Corporation	8.55	$ 2,359.500 Millions	$ 275.925 Millions
Twist Bioscience Corporation	8.54	$ 362.273 Millions	$ 42.402 Millions

Date modified: 2026-10-15T05:23:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.